Clinical Trial Update: Utility of NGAL to Diagnose AKI in Critically Ill Children

View source ↗

Summary

The clinical trial evaluates the biomarker NGAL for diagnosing acute kidney injury in critically ill children. The update lists the trial status as UNKNOWN and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Aga Khan University | Conditions: Acute Kidney Injury in Critically Ill Children | Status: UNKNOWN